Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Regeneus Ltd. ( (AU:CMB) ).
Cambium Bio Limited has reported its financial results for the year ending June 30, 2025. The company experienced a significant increase in revenue from ordinary activities, rising by 419% compared to the previous year. However, the net profit for the year showed a substantial decline, with a 70% decrease in profit from ordinary activities after income tax attributable to members. No dividends were proposed or paid for the current year. The company’s Annual General Meeting is scheduled for October 16, 2025, with director nominations due by September 10, 2025.
More about Regeneus Ltd.
Average Trading Volume: 15,262
Technical Sentiment Signal: Sell
Current Market Cap: A$8.04M
For an in-depth examination of CMB stock, go to TipRanks’ Overview page.